We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Nanosyn and PCAS Announce the Signing of a Joint-Venture Agreement to Operate PCAS-NANOSYN

News   Aug 13, 2009

 
Nanosyn and PCAS Announce the Signing of a Joint-Venture Agreement to Operate PCAS-NANOSYN
 
 
 

RELATED ARTICLES

RNA Folding Insights Lead to New Therapeutics and Synthetic Biology Technologies

News

A research team has uncovered a new understanding of how RNA molecules act as cellular "biosensors" to monitor and respond to changes in the environment by controlling gene expression.

READ MORE

Bioactive Agents Improve Synthetic Bone Substitutes

News

Synthetic bone substitutes are promising materials for bone defect repair, but their efficacy can be substantially improved by bioactive agents such as growth factors. In a new study, researchers have modified beta-tricalcium phosphate (β-TCP) with increasing quantities of bone morphogenetic protein 2 (BMP-2) derived from E. coli and shown improved bone healing.

READ MORE

A New Way of Creating the Building Blocks of Drugs

News

A team have discovered how to synthesize the most common molecule arrangement in medicine, a scientific discovery that could change the way a number of drugs are produced.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE